Bahadır Köylü

18PUBLICATIONS
154CO-AUTHORS
Predictive and prognostic markersCell physiologyClinical midwiferyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 26, 2026
Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study.

|Apr 27, 2026
Molecular Profiling and Survival Outcomes in Pancreatic Ductal Adenocarcinoma: A Multicenter Real-World Study from Turkey.

|Apr 22, 2026
The Clinical Significance of Gallium-68 PSMA-11 PET-Derived SUVmax in the Management of Metastatic Hormone-Sensitive Prostate Cancer.

|Mar 26, 2026
Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO).

Erman Akkus, Mehmet Kayaalp, Müzeyyen Aslı Ergözoğlu

|Mar 16, 2026
Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study.

Taha Koray Sahin, Fatih Kemik, Harun Muglu

|Feb 27, 2026
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis.

Baris Koksal, Hasan Cagri Yildirim, Deniz Can Guven

Pageof 3

Frequent Collaborators

6 joint publications

Harun Muglu

4 joint publications

Ahmet Bilici

3 joint publications

Taha Koray Sahın

3 joint publications

Elif Sahin